John Hassell

Affiliations: 
McMaster University, Hamilton, ON, Canada 
Area:
Molecular Biology
Google:
"John Hassell"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gwynne WD, Shakeel MS, Girgis-Gabardo A, et al. (2021) The Role of Serotonin in Breast Cancer Stem Cells. Molecules (Basel, Switzerland). 26
Gwynne WD, Shakeel MS, Girgis-Gabardo A, et al. (2020) Antagonists of the serotonin receptor 5A target human breast tumor initiating cells. Bmc Cancer. 20: 724
Gwynne WD, Shakeel MS, Wu J, et al. (2019) Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells. Cellular & Molecular Biology Letters. 24: 59
Atiya HI, Dvorkin-Gheva A, Hassell J, et al. (2019) Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis. Anticancer Research. 39: 2277-2287
Shenouda MM, Gillgrass A, Nham T, et al. (2017) Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Research : Bcr. 19: 76
Gwynne WD, Hallett RM, Girgis-Gabardo A, et al. (2017) Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts. Oncotarget
Bassey-Archibong BI, Rayner LG, Hercules SM, et al. (2017) Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells. Cell Death & Disease. 8: e2689
Dias K, Dvorkin-Gheva A, Hallett RM, et al. (2017) Claudin-Low Breast Cancer; Clinical & Pathological Characteristics. Plos One. 12: e0168669
Gillgrass A, Pond G, Levine M, et al. (2017) Abstract P4-12-09: The immune response in triple negative breast cancer Cancer Research. 77
Hallett RM, Girgis-Gabardo A, Gwynne WD, et al. (2016) Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. Oncotarget
See more...